Reply to the letter to the editor 'Borderline resectable pancreatic cancer: an evolving concept' by Petrucciani et al

J W Gilbert; B Wolpin; T Clancy; J Wang; H Mamon; A B Shinagare; J Jagannathan; M Rosenthal

doi:10.1093/annonc/mdx273

Reply to the letter to the editor 'Borderline resectable pancreatic cancer: an evolving concept' by Petrucciani et al

Ann Oncol. 2017 Sep 1;28(9):2316. doi: 10.1093/annonc/mdx273.

Authors

J W Gilbert^{1

2

3}, B Wolpin^{3

4}, T Clancy^{3

5}, J Wang^{3

5}, H Mamon^{3

6}, A B Shinagare^{1

2

3}, J Jagannathan^{1

2

3}, M Rosenthal^{1

2

3}

Affiliations

¹ Department of Imaging, Dana-Farber Cancer Institute, Boston.
² Department of Radiology, Brigham and Women's Hospital, Boston.
³ Harvard Medical School, Boston.
⁴ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston.
⁵ Division of Surgical Oncology, Department of Surgery, Brigham and Women's Hospital and Gastrointestinal Surgical Center, Dana-Farber/Brigham and Women's Cancer Center, Boston.
⁶ Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Humans
Pancreatic Neoplasms*

Grants and funding

U01 CA210171/CA/NCI NIH HHS/United States